(Q40676271)

22 September 2017

Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells (English)

1 reference

22 September 2017

Daniela Tavian

1

1 reference

22 September 2017

Alessandro Salvi

series ordinal

2

1 reference

22 September 2017

Giuseppina De Petro

series ordinal

3

1 reference

22 September 2017

Sergio Barlati

series ordinal

4

1 reference

22 September 2017

1 February 2003

1 reference

22 September 2017

1 reference

22 September 2017

10

1 reference

22 September 2017

2

1 reference

22 September 2017

112-120

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700533

22 September 2017

0 references

cites work

Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Regulation of integrin function by the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Structure and function of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Clonal Origin of Recurrent Hepatocellular Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Urokinase induces expression of its own receptor in Beas2B lung epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700533

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700533

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference